Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy

Jonathan Rodriguez(University of California, Irvine), Richard A. Van Etten(University of California, Irvine)

bioRxiv (Cold Spring Harbor Laboratory)

October 14, 2022

10.1101/2022.10.11.511822

Cited by 3

Related Papers

Tyrosine Kinases as Targets for Cancer Therapy

|New England Journal of Medicine|2005|1.4k

Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F

|PLoS ONE|2006|215